U.S. Markets closed

Shire plc (SHP.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
4,778.50+68.50 (+1.45%)
At close: 5:02PM BST
People also watch
SN.LWPP.LAZN.LSMIN.LSDR.L
Interactive chart
Previous Close4,710.00
Open4,731.00
Bid4,700.00 x 51000
Ask4,800.00 x 53800
Day's Range4,731.00 - 4,788.00
52 Week Range2,707.19 - 5,377.00
Volume2,002,999
Avg. Volume2,275,354
Market Cap43.03B
Beta1.79
PE Ratio (TTM)147.03
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.26 (0.42%)
Ex-Dividend Date2016-09-08
1y Target EstN/A
  • American City Business Journals2 days ago

    Shire and tiny Lexington biotech say hemophilia drug trial misses mark

    Shares of Xenetic Biosciences sank on Monday after the Lexington biotech announced a significant setback in its collaboration with Shire plc on a hemophilia drug. Xenetic (XBIO), which has seven employees, announced disappointing results from a Phase 1/2 study of Shire’s SHP656 hemophilia A treatment using Xenetic’s PolyXen technology, which is designed to extend the half-life of drugs. While the technology did extend the half-life of SHP656, and there were no major side effects, Xenetic said the trial had missed its goal of enabling once-weekly dosing.

  • Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug
    Zacks5 days ago

    Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug

    Shire plc (SHPG) announced positive top-line results from the phase III study, HELP, on HAE candidate, lanadelumab.

  • Zacks5 days ago

    Company News for May 19, 2017

    Companies in the News are: LB,P,INCY,MRK,SHPG